<DOC>
	<DOCNO>NCT01740934</DOCNO>
	<brief_summary>This multi-site , four-visit , eight-week , double-blind , randomize , vehicle-controlled , parallel-group study follow eight-week open-label extension evaluate safety , tolerability , potential effect Anatabloc Facial Cream . The secondary aim evaluate Anatabloc Facial Cream improve appearance skin subject mild moderate rosacea .</brief_summary>
	<brief_title>A Study Evaluate Safety , Tolerability , Effects Anatabloc® Crème Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>age 2570 year diagnose mild moderate rosacea allergy sensitivity study product component severe rosacea current use glucocorticoid , antiacne product , antibiotic , topical retinoids , vasoactive drug recent oral isotretinoin use current use anatabinecontaining supplement ( ie . Anatabloc , Anatabloc Unflavored , CigRx )</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>rosacea</keyword>
	<keyword>anatabine</keyword>
	<keyword>Anatabloc</keyword>
	<keyword>dermatology</keyword>
</DOC>